Compare HALO & CIGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HALO | CIGI |
|---|---|---|
| Founded | 1998 | 1972 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 6.0B |
| IPO Year | 2001 | 1995 |
| Metric | HALO | CIGI |
|---|---|---|
| Price | $63.56 | $106.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 6 |
| Target Price | $78.18 | ★ $174.00 |
| AVG Volume (30 Days) | ★ 1.8M | 584.4K |
| Earning Date | 05-11-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 0.27% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 2.56 | N/A |
| Revenue | ★ $151,862,000.00 | N/A |
| Revenue This Year | $28.24 | $16.74 |
| Revenue Next Year | $12.79 | $8.04 |
| P/E Ratio | ★ $26.00 | $57.57 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $47.50 | $98.97 |
| 52 Week High | $82.22 | $171.20 |
| Indicator | HALO | CIGI |
|---|---|---|
| Relative Strength Index (RSI) | 29.05 | 31.57 |
| Support Level | $63.85 | $98.97 |
| Resistance Level | $65.40 | $132.47 |
| Average True Range (ATR) | 1.85 | 4.10 |
| MACD | -0.67 | -0.13 |
| Stochastic Oscillator | 1.18 | 0.45 |
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.
Colliers International Group Inc provides commercial real estate professional services and investment management to corporate and institutional clients across different countries around the world. Its operating segments are Commercial Real Estate, Engineering and Investment Management. Maximum revenue for the company is generated from its Commercial Real Estate segment, which offers services like transaction and debt finance services, outsourcing in property management, valuation and advisory, loan servicing, and others. Geographically, the company generates maximum revenue from the United States followed by Canada, Euro currency countries, Australia, the United Kingdom, Poland, China, India, and other regions.